Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers126
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State124
News from NLA110
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine94
The Effect of Estrogen and Testosterone on Cholesterol Crystallization63
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice58
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease58
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis55
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis51
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma49
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia47
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery45
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor43
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice40
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece40
Lipoprotein(a) concentrations across a global cross-sectional registry39
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories39
Care of youth with lipid disorders: A brief provider survey34
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study34
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-1928
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss28
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis27
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse27
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study26
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes26
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease25
0.04025411605835